D
Do Young Kim
Researcher at Yonsei University
Publications - 737
Citations - 18320
Do Young Kim is an academic researcher from Yonsei University. The author has contributed to research in topics: Hepatocellular carcinoma & Medicine. The author has an hindex of 58, co-authored 674 publications receiving 15091 citations. Previous affiliations of Do Young Kim include University of Ulsan & Fred Hutchinson Cancer Research Center.
Papers
More filters
Journal ArticleDOI
Less Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection.
Hye Won Lee,Gi Hong Choi,Do Young Kim,Young Nyun Park,Kyung Sik Kim,Jin Sub Choi,Sang Hoon Ahn,Kwang Hyub Han +7 more
TL;DR: Noncirrhotic HCC showed better disease-free survival (DFS) and overall survival (OS) after resection than cirrhosis-related HCC, although noncirRhotic H CC presented more aggressively.
Journal ArticleDOI
Serum PD-1 Levels Change with Immunotherapy Response but Do Not Predict Prognosis in Patients with Hepatocellular Carcinoma
Hye Won Lee,Kyung Joo Cho,Soon Young Shin,Ha Yan Kim,Eun Ju Lee,Beom Kyung Kim,Seung Up Kim,Jun Yong Park,Do Young Kim,Sang Hoon Ahn,Kwang Hyub Han +10 more
TL;DR: This work investigated the clinical significance of PD-1 and PD-L1 in patients with HCC and found that a high expression level of programmed death-ligand 1 (PD-L 1) is a possible prognostic indicator for poor outcome in other malignancies.
Journal ArticleDOI
Staging for hepatocellular carcinoma in light of tumor heterogeneity: Time to change or update?
Do Young Kim,Kwang Hyub Han +1 more
TL;DR: The Hong Kong Liver Cancer staging system, proposed in 2014 and internally validated, tried to address the weaknesses of the BCLC and extend the role of resection and transarterial chemoembolization in subsets of patients with intermediate and advanced stages, but due to several limitations, this staging system cannot be generalized worldwide.
Journal ArticleDOI
Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B
Hye Yeon Chon,Jae Seung Lee,Hye Won Lee,Ho Soo Chun,Beom Kyung Kim,Jun Yong Park,Do Young Kim,Sang Hoon Ahn,Seung Up Kim +8 more
TL;DR: Risk prediction models for hepatocellular carcinoma (HCC) development are available, but the influence of antiviral therapy (AVT) on these models in patients with chronic hepatitis B is unknown.
Journal ArticleDOI
Human chorionic gonadotropin-administered natural cycle versus spontaneous ovulatory cycle in patients undergoing two pronuclear zygote frozen-thawed embryo transfer
You-Jung Lee,Chung-Hoon Kim,Do Young Kim,Jun-Woo Ahn,Sung-Hoon Kim,Hee-Dong Chae,Byung-Moon Kang +6 more
TL;DR: It is demonstrated that HCG administration for ovulation triggering in natural cycle reduces the number of hospital visits for follicular monitoring without any detrimental effect on FTET outcome when compared with spontaneous ovulation cycles in infertile patients undergoing FTET in natural ovulatory cycles.